StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read More
At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read More
StopAfib.org interviews Dr. Sanjiv Narayan of the University of California, San Diego Find more information on this topic, and Dr. Narayan, at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. Sanjiv Narayan updates us on the progress of his FIRM (focal impulse and rotor modulation) ablation research and …
Read More
Findings presented at Heart Rhythm 2010 showed that stopping atrial fibrillation—whether through medication, surgery, or in the case of this study, catheter ablation— could potentially prevent the risk of developing Alzheimer’s disease and other dementias and also reduce the risk of stroke and death. Doctors John D. Day, MD, and T. Jared Bunch, MD, at …
Read More